Crinetics Pharmaceuticals, Inc. (CRNX)
84.95
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 16:00
Crinetics Pharmaceuticals Research and Development Expense (TTM) : 371.81M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 371.81M |
| March 31, 2026 | 351.77M |
| December 31, 2025 | 328.17M |
| September 30, 2025 | 309.89M |
| June 30, 2025 | 281.57M |
| March 31, 2025 | 259.82M |
| December 31, 2024 | 237.37M |
| September 30, 2024 | 216.91M |
| June 30, 2024 | 199.34M |
| March 31, 2024 | 182.11M |
| December 31, 2023 | 167.43M |
| September 30, 2023 | 158.82M |
| June 30, 2023 | 147.00M |
| March 31, 2023 | 139.42M |
| December 31, 2022 | 129.24M |
| September 30, 2022 | 116.90M |
| June 30, 2022 | 106.51M |
| March 31, 2022 | 93.98M |
| Date | Value |
|---|---|
| December 31, 2021 | 83.33M |
| September 30, 2021 | 75.57M |
| June 30, 2021 | 67.68M |
| March 31, 2021 | 59.78M |
| December 31, 2020 | 56.05M |
| September 30, 2020 | 51.59M |
| June 30, 2020 | 49.96M |
| March 31, 2020 | 47.88M |
| December 31, 2019 | 41.51M |
| September 30, 2019 | 37.01M |
| June 30, 2019 | 32.08M |
| March 31, 2019 | 27.01M |
| December 31, 2018 | 24.48M |
| September 30, 2018 | 19.39M |
| June 30, 2018 | 15.03M |
| March 31, 2018 | 11.89M |
| December 31, 2017 | 9.233M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.907B |
| Johnson & Johnson | 15.06B |
| Eli Lilly & Co. | 14.60B |
| Bristol Myers Squibb Co. | 9.548B |
| Corcept Therapeutics, Inc. | 253.86M |